Evidence map›Paper›PMID 29045862›Full record

ArticleBiophysical journal2017

The Two-State Prehensile Tail of the Antibacterial Toxin Colicin N.

Christopher L Johnson, Alexandra S Solovyova, Olli Hecht, Colin Macdonald, Helen Waller, J Günter Grossmann, Geoffrey R Moore, Jeremy H Lakey

Open access · hybridAbstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Accurate model of liquid-liquid phase behavior of intrinsically disordered proteins from optimization of single-chain properties.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Christopher L JohnsonCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
Alexandra S SolovyovaCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom. Electronic address: alexandra.solovyova@ncl.ac.uk.
Olli HechtCentre for Structural and Molecular Biology, School of Chemistry, University of East Anglia, Norwich, United Kingdom.
Colin MacdonaldCentre for Structural and Molecular Biology, School of Chemistry, University of East Anglia, Norwich, United Kingdom.
Helen WallerCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
J Günter GrossmannInstitute of Integrative Biology, Structural and Chemical Biology, Liverpool, United Kingdom.
Geoffrey R MooreCentre for Structural and Molecular Biology, School of Chemistry, University of East Anglia, Norwich, United Kingdom.
Jeremy H LakeyCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.
Newcastle University · GBUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C507396/1Wellcome Trust 080342Wellcome Trust 093581
6 · The paper itself

Abstract

Intrinsically disordered regions within proteins are critical elements in many biomolecular interactions and signaling pathways. Antibacterial toxins of the colicin family, which could provide new antibiotic functions against resistant bacteria, contain disordered N-terminal translocation domains (T-domains) that are essential for receptor binding and the penetration of the Escherichia coli outer membrane. Here we investigate the conformational behavior of the T-domain of colicin N (ColN-T) to understand why such domains are widespread in toxins that target Gram-negative bacteria. Like some other intrinsically disordered proteins in the solution state of the protein, ColN-T shows dual recognition, initially interacting with other domains of the same colicin N molecule and later, during cell killing, binding to two different receptors, OmpF and TolA, in the target bacterium. ColN-T is invisible in the high-resolution x-ray model and yet accounts for 90 of the toxin's 387 amino acid residues. To reveal its solution structure that underlies such a dynamic and complex system, we carried out mutagenic, biochemical, hydrodynamic and structural studies using analytical ultracentrifugation, NMR, and small-angle x-ray scattering on full-length ColN and its fragments. The structure was accurately modeled from small-angle x-ray scattering data by treating ColN as a flexible system, namely by the ensemble optimization method, which enables a distribution of conformations to be included in the final model. The results reveal, to our knowledge, for the first time the dynamic structure of a colicin T-domain. ColN-T is in dynamic equilibrium between a compact form, showing specific self-recognition and resistance to proteolysis, and an extended form, which most likely allows for effective receptor binding.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsColicinsElasticityEscherichia coliEscherichia coli ProteinsHydrodynamicsIntrinsically Disordered ProteinsMembrane ProteinsModels, MolecularMutationNuclear Magnetic Resonance, BiomolecularPorinsProtein ConformationProtein DomainsSaccharomyces cerevisiae ProteinsAnti-Bacterial AgentsASI1 protein, S cerevisiaeColicinsEscherichia coli ProteinsIntrinsically Disordered ProteinsMembrane ProteinsOmpF proteinPorinsSaccharomyces cerevisiae ProteinsSolutionstolA protein, E coli

Identifiers

PMID29045862
PMCPMC5647543
OpenAlexW2766770111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.